Switch theme
Sign up to access all valuation multiples
Cosmecca Korea Co Ltd is engaged in research, development, and production of cosmetics. It offers various products including skincare, makeup products, and functional products. The skincare products consist of Cream, Essence, Cleansers, Korean herbal products, Exfoliators, and mask sheets. Its functional products comprise of skincare products with specific functions such as UV blocking, brightening, and wrinkle care. The Makeup products range comprise of BB & CC cream, Skin cover balms, Makeup base, Foundation, Concealer, Lipstick, Mascara, and Powders.
1999
n/a
LTM Revenue $372M
LTM EBITDA $55.1M
$375M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Cosmecca Korea has a last 12-month revenue of $372M and a last 12-month EBITDA of $55.1M.
In the most recent fiscal year, Cosmecca Korea achieved revenue of $357M and an EBITDA of $60.4M.
Cosmecca Korea expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Cosmecca Korea valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $321M | $357M | XXX | XXX | XXX |
| Gross Profit | $44.3M | $73.0M | XXX | XXX | XXX |
| Gross Margin | 14% | 20% | XXX | XXX | XXX |
| EBITDA | $45.6M | $60.4M | XXX | XXX | XXX |
| EBITDA Margin | 14% | 17% | XXX | XXX | XXX |
| Net Profit | $1.8M | $15.2M | XXX | XXX | XXX |
| Net Margin | 1% | 4% | XXX | XXX | XXX |
| Net Debt | $61.2M | $49.5M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Cosmecca Korea's stock price is KRW 46050 (or $31).
Cosmecca Korea has current market cap of KRW 492B (or $335M), and EV of KRW 550B (or $375M).
See Cosmecca Korea trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $375M | $335M | XXX | XXX | XXX | XXX | $2.78 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Cosmecca Korea has market cap of $335M and EV of $375M.
Cosmecca Korea's trades at 1.0x LTM EV/Revenue multiple, and 6.8x LTM EBITDA.
Analysts estimate Cosmecca Korea's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Cosmecca Korea and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $375M | XXX | XXX | XXX |
| EV/Revenue | 1.0x | XXX | XXX | XXX |
| EV/EBITDA | 6.2x | XXX | XXX | XXX |
| P/E | 11.5x | XXX | XXX | XXX |
| P/E/Growth | 0.6x | XXX | XXX | XXX |
| EV/FCF | 26.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpCosmecca Korea's NTM/LTM revenue growth is 13%
Cosmecca Korea's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, Cosmecca Korea's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Cosmecca Korea's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Cosmecca Korea and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 11% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 32% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 30% | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 3% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 12% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cosmecca Korea acquired XXX companies to date.
Last acquisition by Cosmecca Korea was XXXXXXXX, XXXXX XXXXX XXXXXX . Cosmecca Korea acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Cosmecca Korea founded? | Cosmecca Korea was founded in 1999. |
| Where is Cosmecca Korea headquartered? | Cosmecca Korea is headquartered in South Korea. |
| Who is the CEO of Cosmecca Korea? | Cosmecca Korea's CEO is Mr. Lim-Rae Jo. |
| Is Cosmecca Korea publicy listed? | Yes, Cosmecca Korea is a public company listed on KRX. |
| What is the stock symbol of Cosmecca Korea? | Cosmecca Korea trades under 241710 ticker. |
| When did Cosmecca Korea go public? | Cosmecca Korea went public in 2016. |
| Who are competitors of Cosmecca Korea? | Similar companies to Cosmecca Korea include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of Cosmecca Korea? | Cosmecca Korea's current market cap is $335M |
| What is the current revenue of Cosmecca Korea? | Cosmecca Korea's last 12-month revenue is $372M. |
| What is the current EBITDA of Cosmecca Korea? | Cosmecca Korea's last 12-month EBITDA is $55.1M. |
| What is the current EV/Revenue multiple of Cosmecca Korea? | Current revenue multiple of Cosmecca Korea is 1.0x. |
| What is the current EV/EBITDA multiple of Cosmecca Korea? | Current EBITDA multiple of Cosmecca Korea is 6.8x. |
| What is the current revenue growth of Cosmecca Korea? | Cosmecca Korea revenue growth between 2023 and 2024 was 11%. |
| Is Cosmecca Korea profitable? | Yes, Cosmecca Korea is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
